|
Merck Millipore shuts Bangalore GeNei, assists its 39 FTEs & 12 contract staff to transit with alternative jobs
|
|
Nandita Vijay, Bengaluru
August 29 , 2015
|
|
|
Merck Millipore shut down the Bangalore GeNei which it acquired in 2009
as part of its strategy to keep pace with globally relevant portfolio of
lab instrumentation and consumables.
The Bangalore GeNei site
manufactured teaching kits, techware and molecular biology reagents.
Production has stopped at the site on July 31, 2015 and decommissioning
activities are currently on-going. This site was employing 39 full time
employees (FTEs) and 12 contract personnel. But now the company’s India
management has been in detailed dialogue with the impacted employees,
supporting their transition and evaluating alternate opportunities where
possible, informed Merck Millipore spokespersons.
Moving
forward, Merck Millipore will continue to focus on its core businesses
to build on its inherent strengths in genomics, proteomics, cell
culture, cell analysis, western blotting, disease research tools,
analytical sample preparation and bio chemicals, they added.
“India
has been a priority market and will continue to be so for Merck
Millipore. Recently in January, 2015, a campus expansion was announced
to enhance capabilities of the additional Bengaluru plant. The facility
has a domestic manufacturing and export oriented unit (EOU) serving both
international and domestic customers. It is the only location for Merck
Millipore manufacturing Standard Tangential Flow Filtration and
Chromatography Purification systems. The Provantage Lab and Bio
Manufacturing Science Network lab in Bengaluru cater to process
development and validation services for the biotech and classical pharma
industry,” they informed.
In June 2014, Merck Millipore launched
its new process solutions formulation laboratory in Navi Mumbai,
Maharashtra, which is its first lab outside Europe. The spokespersons
pointed out, “Merck Millipore is well placed for the needs of the market
in India.”
In September, 2014 Merck and Sigma-Aldrich inked a
definitive agreement where the former would acquire Sigma-Aldrich for
$17.0 billion (€13.1 billion), to become one of the leading players in
the $130 billion global life science industry. Now the combined company
would be able to serve life science customers globally with a highly
attractive set of established brands and an efficient supply chain that
can support supply of over 300,000 products. In the laboratory &
academia business, together Merck Millipore and Sigma-Aldrich is
positioned to offer a complementary range of products across laboratory
chemicals, biologics and reagents. Specifically in bio-pharma
production, Sigma-Aldrich would complement Merck Millipore’s existing
products and capabilities with additions along the entire value chain of
drug production and validation.
Bangalore GeNei founded by the
leading scientist Dr Padmanabhan Babu in 1989 was manufacturing
restriction enzymes, modifying enzymes, DNA vectors and molecular weight
markers at its facility in Peenya, Bengaluru. In mid December 15, 2003,
it was taken over by the Chennai-based Sanmar Speciality Chemicals
Limited (SSCL) and subsequently acquired by Merck KGaA in 2009.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|